Assignee
GENMAB AS
DK79 patents
Top patents by PatentIndex Score
US7153507B2Dec 26, 2006
Human antibodies specific for interleukin 15 (IL-15)
GENMAB AS367 citations98
US7829673B2Nov 9, 2010
Antibodies against CD38 for treatment of multiple myeloma
GENMAB AS148 citations97
US7595378B2Sep 29, 2009
Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
GENMAB AS64 citations97
US7247301B2Jul 24, 2007
Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
GENMAB AS215 citations97
US7438907B2Oct 21, 2008
Human monoclonal antibodies against CD25
GENMAB AS50 citations95
US7282568B2Oct 16, 2007
Human monoclonal antibodies against interleukin 8 (IL-8)
GENMAB AS39 citations95
US11440966B2Sep 13, 2022
Multispecific antibodies against CD40 and CD137
GENMAB AS12 citations94
US10597464B2Mar 24, 2020
Heterodimeric antibody Fc-containing proteins and methods for production thereof
GENMAB AS35 citations93
US10590206B2Mar 17, 2020
Inert format
GENMAB AS29 citations93
US10544220B2Jan 28, 2020
Bispecific antibodies against CD3 and CD20
GENMAB AS18 citations93
US10407501B2Sep 10, 2019
Humanized or chimeric CD3 antibodies
GENMAB AS15 citations93
US10344050B2Jul 9, 2019
Production of heterodimeric proteins
GENMAB AS40 citations91
US9944711B2Apr 17, 2018
Antibodies against human CD38
GENMAB AS16 citations91
US7850962B2Dec 14, 2010
Human monoclonal antibodies against CD20
GENMAB AS27 citations91
US7247304B2Jul 24, 2007
Methods of treating using anti-IL-15 antibodies
GENMAB AS21 citations90
US11866514B2Jan 9, 2024
Heterodimeric antibody Fc-containing proteins and methods for production thereof
GENMAB AS5 citations85
US11485796B2Nov 1, 2022
Inert format
GENMAB AS6 citations85
US11091557B2Aug 17, 2021
Methods of producing multispecific antibodies against CD40 and CD137
GENMAB AS10 citations85
US11548952B2Jan 10, 2023
Bispecific antibody against CD3 and CD20 in combination therapy for treating diffuse large B-cell lymphoma
GENMAB AS7 citations84
US11084882B2Aug 10, 2021
Multispecific antibodies against CD40 and CD137
GENMAB AS8 citations84
US10906991B2Feb 2, 2021
Bispecific antibodies and methods for production thereof
GENMAB AS15 citations84
US9657107B2May 23, 2017
Monoclonal antibodies against c-Met
GENMAB AS9 citations84
US11608383B2Mar 21, 2023
Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma
GENMAB AS8 citations83
US11535679B2Dec 27, 2022
Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma
GENMAB AS8 citations83
US11492371B2Nov 8, 2022
Production of heterodimeric proteins
GENMAB AS9 citations83
US10512688B2Dec 24, 2019
Antibodies binding AXL
GENMAB AS4 citations83
US10500276B2Dec 10, 2019
Antibodies binding AXL
GENMAB AS4 citations83
US10201607B2Feb 12, 2019
Antibodies binding AXL
GENMAB AS7 citations83
US7329405B2Feb 12, 2008
Human antibodies specific for interleukin 15 (IL-15)
GENMAB AS11 citations83
US9492565B2Nov 15, 2016
Human antibody drug conjugates against tissue factor
GENMAB AS7 citations82
US9714297B2Jul 25, 2017
Human antibodies against tissue factor and methods of use thereof
GENMAB AS9 citations80
US11613575B2Mar 28, 2023
Humanized or chimeric CD3 antibodies
GENMAB AS4 citations74
US11359015B2Jun 14, 2022
Humanized or chimeric CD3 antibodies
GENMAB AS6 citations74
US12077596B2Sep 3, 2024
Multispecific antibodies against CD40 and CD137
GENMAB AS2 citations73
US11939388B2Mar 26, 2024
Multispecific antibodies against CD40 and CD137
GENMAB AS2 citations73
US7622559B2Nov 24, 2009
Human monoclonal antibodies against interleukin 8 (IL-8)
GENMAB AS7 citations73
US11845805B2Dec 19, 2023
Bispecific antibody against CD3 and CD20 in combination therapy for treating diffuse large B-cell lymphoma
GENMAB AS5 citations72
US11046771B2Jun 29, 2021
Monoclonal antibodies against HER2
GENMAB AS2 citations72
US10765743B2Sep 8, 2020
Antibodies binding AXL
GENMAB AS3 citations72
US10351629B2Jul 16, 2019
Recombinant IgG4 monovalent antibodies
GENMAB AS2 citations72
US9598493B2Mar 21, 2017
Human monoclonal antibodies against CD25
GENMAB AS3 citations72
US7585961B2Sep 8, 2009
Nucleic acid encoding human antibodies specific for interleukin 15 (IL-15)
GENMAB AS5 citations72
US11459395B2Oct 4, 2022
Binding agents binding to PD-L1 and CD137 and use thereof
GENMAB AS1 citations71
US11130819B2Sep 28, 2021
Antibodies
GENMAB AS1 citations70
US11008399B2May 18, 2021
Antibodies
GENMAB AS2 citations70
US11858995B2Jan 2, 2024
Bispecific antibodies against CD3 and CD20 for treating chronic lymphocytic leukemia
GENMAB AS4 citations69
US12589150B2Mar 31, 2026
Antibodies binding AXL
GENMAB AS0 citations62
US11578141B2Feb 14, 2023
Bispecific antibodies against HER2 and CD3
GENMAB AS1 citations62
US11512140B2Nov 29, 2022
Monoclonal antibodies against c-Met
GENMAB AS0 citations62
US12570751B2Mar 10, 2026
Binding agents binding to PD-L1 and CD137 and use thereof
GENMAB AS0 citations61
Showing the top 50 of 79 patents by PatentIndex Score.